The peptide arrays stained with ...

Slides:

Advertisements

Similar presentations

Clinical and serological evolution of the presented case.

Advertisements

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Data-selection process

Figure 1 Flow diagram detailing the systematic review process.

(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.

(A) Calcinosis cutis on the extensor side of the left upper arm ...

Figure 1 Mechanism of mortality benefit associated with radial access

(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ...

(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.

Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.

(A) The heat map shows an overview ...

(a) Detection of ANETA. NETs were reacted with the ...

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

AHA: American Heart Association; ALT: ...

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

(A) Axial ... (A) Axial images showed symmetric, strong high intensity in the connective tissues surrounded by femoral muscles and mild high intensity.

bDMARD: biologic DMARD.

(A) Upper ... (A) Upper gastroduodenoscopy showing gastric antral vascular ectasia with visible bleeding. (B) Nailfold capillaroscopy showing dilated capillaries.

(A) Pelvic X-ray showing diffuse osteoaddensing ...

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

RCTs: randomized controlled ...

(A, B) Upon presentation large, scaly, annular plaques with well-defined, erythematous, raised ... (A, B) Upon presentation large, scaly, annular plaques.

Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.

Fig. 1 Graphical representation of improving mortality in stroke patients since the inception of a national stroke ... “Graph courtesy of George Dunn,

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

High IFN-α levels were found in patient’s serum, and ...

Take home figure The protective role of CNP/NPR-B/NPRC.

Fig. 3 Interrelationship between themes describing the experiences of people with shoulder disorders Unless provided in the caption above, the following.

A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs

x-axis, post-partum days. Closed ...

Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.

Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs

Fig. 1 Flow chart of included patients for analyses

Rats were treated for 21 days ...

Fig. 1 Flow chart for selection of study subjects

Increased ... Increased brain connectivity between the SMN and left insula (A), DMN and right middle frontal gyrus (B) and DAN and bilateral medial prefrontal.

Prevalence and distribution of ...

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

(A, B) Representative TEM images from the skin ...

Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.

Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.

Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.

(A) Hypoechoic ‘halo sign’ of ...

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.

Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.

Fig. 1 Comparison of LOX concentrations between study groups

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Patient selection

The independent additive value of total greyscale + power Doppler synovitis ... The independent additive value of total greyscale + power Doppler synovitis.

Fig. 1 A network representation of top 100 co-occurring terms

Fig. 1 Statistics of the main characters’ dialogues.

Figure 1. Longitudinal measures of HIV persistence and immunologic phenotype/function during anti-PD-1 therapy are ... Figure 1. Longitudinal measures.

(A) Serum IgM ... (A) Serum IgM anti-phosphorylcholine (PC) antibodies were diminished in SLE patients (n = 197) compared with controls (n = 99) [60.53.

The figure shows the fraction of ...

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.

Fig. 1: World distribution of field sampling locations of Aedes aegypti and Aedes mascarensis screened for Wolbachia ... Fig. 1: World distribution of.

(A, B) Upon presentation large, scaly, annular plaques with well-defined, erythematous, raised ... (A, B) Upon presentation large, scaly, annular plaques.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Table 2. Mean noise level results for hand dryers in dBA

Presentation transcript:

The peptide arrays stained with ... The peptide arrays stained with pools of Th/To positive SSc serum samples (A, B) show several immunoreactive regions in all proteins. Reactivity with the pool of samples derived from SLE sera showed minor reactivity (C). Peptides that showed reactivity (>200 units) with at least one of the two Th/To serum pools, but not with the SLE pool are shown in D. In E, epitope map highlights main reactive peptides. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez123, https://doi.org/10.1093/rheumatology/kez123 The content of this slide may be subject to copyright: please see the slide notes for details.

The number of peptides that ... The number of peptides that showed a reactivity of >200 units with at least one of the Th/To pools, but not with the SLE control pool, are displayed. For both Rpp25 and hPop1, more peptides reacted with pool 1, but not with pool 2. Rpp38 showed the highest number of peptides that reacted with both Th/To sample pools. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez123, https://doi.org/10.1093/rheumatology/kez123 The content of this slide may be subject to copyright: please see the slide notes for details.

The levels of anti-Rpp25 (recombinant ... The levels of anti-Rpp25 (recombinant full-length protein) and anti-Rpp38 (the major Rpp38 peptide) antibodies are shown as measured by chemiluminescence immunoassay (CIA) in A. In B, reactivity is displayed according to the IIF pattern. The individual ICAP pattern as well as two groups [with (w) and without (w/o) any AC-08 pattern] are presented. lcSSc: limited cutaneous SSc; dcSSc: diffuse cutaneous); IIM: idiopathic inflammatory myopathies; HBV: hepatitis B virus; HCV: hepatitis C virus; HIV: human immunodeficiency virus; AC-01: homogeneous; AC-03: centromere; AC-04: fine speckled; AC-05: large coarse speckled; AC-08: homogeneous nucleolar; AC-09: clumpy nucleolar; AC-10: punctate nucleolar; AC-12: punctate nuclear envelop; AC-20: cytoplasmic fine speckled; AC-21: cytoplasmic anti-mitochondrial; AC-22: cytoplasmic Golgi-like. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez123, https://doi.org/10.1093/rheumatology/kez123 The content of this slide may be subject to copyright: please see the slide notes for details.

A: Correlation between anti-Rpp25 and anti-Rpp38 229–243 peptide ... A: Correlation between anti-Rpp25 and anti-Rpp38 <sup>229–243</sup> peptide antibodies. The reactivity between anti-Rpp25 and anti-Rpp38 peptide antibodies measured in 299 samples (203 SSc, 81 controls and 13 with unknown diagnosis) using a chemiluminescence assay showed significant correlation (rho = 0.44, 95% CI 0.35, 0.53; P < 0.0001). However, subsets of some patients either reacted with Rpp25 or with the novel Rpp38 derived peptide. B: Using a mixture of Rpp25 and Rpp38 coupled beads, samples that were positive for either of the two antigens were detected. All values on the ordinate axis are expressed as relative light units (RLU). QF: QUANTA Flash. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez123, https://doi.org/10.1093/rheumatology/kez123 The content of this slide may be subject to copyright: please see the slide notes for details.